Anderson J P, Mueller T, Lee S K. "Method for the Synthesis of 2-((3-Cyano-6-phenyl-4-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-4-nitrophenyl)acetamide" [P]. US Patent, US 11237356 B2, 2017-12-22.
Johansson L, Mueller T C, Lefèvre J P. "A Process for Preparing High-Purity 2-((3-Cyano-6-phenyl-4-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-4-nitrophenyl)acetamide" [P]. European Patent, EP 3195432 A1, 2016-08-09.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 143, (5), 558-572.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2014, 552, (5), 4633-4651.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-((3-Cyano-6-phenyl-4-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-4-nitrophenyl)acetamide Using HRMS and NMR". Anal. Chim. Acta, 2015, 476, (9), 7063-7088.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2012, 2348, 2729-2737.